SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MDVistnes who wrote (36)9/8/1997 9:40:00 PM
From: Miles Rhyne Hoffman, CFA   of 184
 
"problem...existing...super glues...not biodegradable" - do you know Cryolife? Their FibRx is (said) to be a blood derivative and should work on internal as well as external wounds because, presumably, it is not only biogradable but also organic.

By the way, you can buy Cryolife for a "cheap" multiple of its existing heart valve (and other body parts) business. The potential of FibRx is no longer reflected in the price of the stock... perhaps because a deal+option with Bayer expired around Feb and nothing else has been announced.

I would appreciate your insights.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext